Calls for papers
-
The Japanese Ministry of Health, Labor and Welfare (MHLW) has approved Novartis’s Seebri glycopyrronium bromide inhalation capsules, delivered by the Breezhaler DPI, for the treatment of COPD. The product should be available in Japan by… Read more . . .
-
ABC Laboratories, Columbia, MO. The Senior Scientist / Team Leader is a results-oriented, problem-solver and laboratory supervisor who will support ABC Inhalation Product Development programs. Experience with pMDI, DPI and nasal/pulmonary delivery systems is required.… Read more . . .
-
ABC Laboratories, Columbia, MO. The Principal Scientist/Team Leader is a results-oriented, problem-solver and laboratory supervisor who will support ABC Inhalation Product Development programs. Experience with pMDI, DPI and nasal/pulmonary delivery systems is required. Direct hands-on… Read more . . .
-
The British Pharmacopoeia (BP) Inhaled Products Working Party has published its recommendations for BP monographs for inhalation as of September 17, 2012. According to the document, “Safety and efficacy are critical considerations; the Working Party… Read more . . .
-
GlaxoSmithKline says that it submitted a Japanese New Drug Application (JNDA) for its fluticasone furoate (FF)/vilanterol(VI) dry powder inhaler for the treatment of COPD and asthma on September 25, 2012. The FF/VI combination will be… Read more . . .
-
Hovione has announced the addition of services for crystal design, particle size reduction to the micro or nano-scale, and amorphous solid dispersions. The company, which provides particle engineering, formulation development, and clinical manufacture to Phase… Read more . . .
-
The US Patent and Trade Office has awarded Aegis Therapeutics US Patent No. 8,268,791 for “Alkylglycoside compositions for drug administration.” The company is highlighting the patent’s coverage of fast-acting intranasal triptan formulations for the treatment… Read more . . .
-
Lightlake Therapeutics, which is developing naloxone nasal sprays for several eating disorders, has announced the appointment of former FDA Commissioner David Kessler as a strategic advisor. Kessler is the author of The End of Overeating:… Read more . . .
-
Acton Pharmaceuticals has announced plans to launch its Aerospan flunisolide HFA metered dose inhaler in early 2013 after having received FDA approval for the MDI. The product is approved for for the maintenance treatment of… Read more . . .
-
Belgian biopharmaceutical company Ablynx has announced positive results from a Phase 1 of its ALX-0171 inhaled Nanobody for the treatment of respiratory syncytial virus (RSV) infections. According to the company, the study demonstrated the safety… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA